Feedback / Questions
THN391 - Therini Bio
https://www.globenewswire.com/news-release/2025/07/29/3123157/0/en/Therini-Bio-Announces-First-Patient-Dosed-in-Phase-1b-Trial-of-THN391-in-Alzheimer-s-Disease.html
Jul 29, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next